Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Textron (NYSE:TXT) Q4 Earnings Out — What the Market Is Responding To?

Textron (NYSE:TXT) released its fourth-quarter and full-year 2025 financial results on Wednesday, triggering a sharp market reaction. The company’s shares declined by nearly 8% during the trading session following the announcement.

Team Kalkine | 28 January 2026

How United Parcel (NYSE:UPS) Is Balancing Earnings Pressure With Dividend Commitments

United Parcel Service (NYSE:UPS) reported fourth-quarterrevenueof USD 24.5 billion, slightly ahead of market expectations. Adjustedearningsfor the quarter came in at USD 2.38 per share, exceeding consensus estimates of USD 2.20 per share. For the full year, UPS generated total revenue of USD 88.7 billion, …

Team Kalkine | 28 January 2026

Meta Platforms Reports 22% Revenue Growth in 2025, Announces Major AI Superintelligence Push

Meta Platforms, Inc. (Nasdaq:META) has released its financial results for the quarter and full year ended December 31, 2025.CEO Mark Zuckerberg stated, "We had strong business performance in 2025. I'm looking forward to advancing personal superintelligence for people around the world in 2026."The report …

Team Kalkine | 28 January 2026

Meta Platforms Reports 22% Revenue Growth in 2025, Announces Major AI Superintelligence Push

Meta Platforms, Inc. (Nasdaq:META) has released its financial results for the quarter and full year ended December 31, 2025.CEO Mark Zuckerberg stated, "We had strong business performance in 2025. I'm looking forward to advancing personal superintelligence for people around the world in 2026."The report …

Team Kalkine | 28 January 2026

Fed in Focus as Earnings, Commodities, and Macroeconomic Signals Drive Sentiment

Market Movers:On Tuesday, the top gainers were TEN Holdings, Inc. (+177.17%), followed by Global Interactive Technologies, Inc. (+118.32%). On the contrary, Cardiff Oncology, Inc. (-31.97%), and Commvault Systems, Inc. (-31.10%) declined the most the same day.

Team Kalkine | 28 January 2026

Why CytoDyn (OTC:CYDY) Is Launching an Expanded Access Program for Leronlimab?

CytoDyn Inc. (OTC:CYDY) announced that it has received dedicated funding from an anonymous benefactor to initiate an Expanded Access Program (EAP) for its investigational monoclonal antibody, Leronlimab, in patients with triple-negative breast cancer (TNBC). The funding is earmarked specifically for the establishment and administration …

Team Kalkine | 28 January 2026

Belite Bio Advances Tinlarebant Program—What’s Driving the Stock Move?

Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage biotechnology company, announced the completion of patient enrollment in its Phase 2/3 DRAGON II clinical trial for tinlarebant, a treatment under investigation for Stargardt disease type 1 (STGD1). The study enrolled 60 adolescent subjects, including 15 participants from …

Team Kalkine | 28 January 2026

ASML Registers a Defining Quarter, Demonstrating Both Demand and Delivery

The defining characteristic of enduring wealth creation is ownership of businesses that sit at the irreversible chokepoints of global value chains. ASML Holding NV represents precisely such an enterprise. As the sole provider of extreme ultraviolet (EUV) lithography systems—and the uncontested leader in next-generation …

Team Kalkine | 28 January 2026

What Went Wrong at UnitedHealth (NYSE:UNH) After a 12% Revenue Jump?

UnitedHealth Group Incorporated (NYSE:UNH) saw its shares decline steeply in pre-market trading on January 27 after reporting weakerearningsand issuingrevenueguidance for fiscal year 2026 that fell below the prior year’s level.

Team Kalkine | 28 January 2026

What West Coast (NASDAQ:WCCB)’s Q4 Results Reveal About Its Profit Recovery

West Coast Community Bancorp (NASDAQ:WCCB) released its financial results for the fourth quarter ended 2025, reporting an increase in profitability compared with the same period last year. The company posted netearningsof USD 13.77 million, translating to USD 1.31 per share, compared with USD 3.84 …

Team Kalkine | 28 January 2026
Support

Hi! How can we help you today?

Loading…